Stay updated with the latest onasemnogene-abeparvovec news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on onasemnogene-abeparvovec topics.
New Delhi: The GST rate cuts announced last week will make medicines used for the treatment of critical conditions like multiple myeloma, lung cancer, blood cancer, lymphoma, Gaucher disease, Pompe disease and haemophilia significantly cheaper and help more patients to avail of treatment, health experts said. A pack of leukaemia drug asciminib 60 (40 mg tablets), which used to cost ₹2,35,000 with GST, will become cheaper by ₹25,000, as per data from market research firm PharmaTrac. Obinutuzu ...Read More >
Advocacy group urges swift implementation of procurement process to benefit patients Cure SMA Foundation of India, a parent-led patient advocacy organisation for Spinal Muscular Atrophy (SMA), has commended recent steps taken by the Government of India, the judiciary, and healthcare stakeholders to address rare diseases. The Ministry of Health and Family Welfare and the Delhi High Court have allocated over Rs 900 crore for rare disease treatment, including SMA, marking a milestone for the com ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.